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Background. Thoracoscopic surgery can be associated with considerable postoperative pain.
While the benefits of paravertebral block on pain after thoracotomy have been demonstrated,
no investigations on the effects of paravertebral block on pain after thoracoscopy have been
conducted. We tested the hypothesis that a single-injection thoracic paravertebral block,
performed preoperatively, reduces pain scores after thoracoscopic surgery.
Methods. Of 45 patients recruited, 40 completed the study. They were randomly allocated
to two groups: the paravertebral group received i.v. patient-controlled analgesia (PCA) with
morphine plus single-injection thoracic paravertebral block with bupivacaine 0.375% and adren-
aline 1:200 000 0.4 ml kg1 (n=20). The control group was treated with a back puncture without
injection and morphine PCA (n=20).
Results. The main outcomes recorded during 48 h after surgery were pain scores using the visual
analogue scale (VAS, 0–100). Secondary outcomes were cumulative morphine consumption and
peak expiratory flow rate (PEFR). Half an hour and 24 h after surgery, median (25th–75th
percentiles) VAS on coughing in the paravertebral group was 31.0 (20.0–55.0) and 30.5
(17.5–40.0) respectively and in the control group it was 70.0 (30.0–100.0) and 50.0
(25.0–75.0) respectively. The difference between the groups over the whole observation period
was statistically significant (P<0.05). Twenty-four and 48 h after surgery, median (25th–75th
percentiles) cumulative morphine consumption (mg) was 49.0 (38.3–87.0) and 69.3
(38.8–118.5) respectively in the paravertebral group and 51.2 (36.0–84.1) and 78.1
(38.4–93.1) in the control group (statistically not significant). No differences were found in
PEFR or the incidence of any side-effects between groups.
Conclusion. We conclude that single-shot preoperative paravertebral block improves post-
operative pain treatment after thoracoscopic surgery in a clinically significant fashion.
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In the past few years video-assisted thoracoscopic surgery
(VATS) has been used increasingly. Although it is considered
a less invasive treatment than thoracotomy,1 patients can
experience moderate to severe pain, especially during the
first hours after surgery.2 3 Systemic opioids given with
patient-controlleddevicesmay beused after thoracic surgery4
but the analgesic effect can be limited and undesirable side-
effects may occur.5 Epidural analgesia is highly effective in
relieving pain and promoting recovery of pulmonary function
after thoracotomy.6–9 However, it carries the risk of dural
puncture, nerve lesions10 and hypotension.9 Thoracic
paravertebral analgesia is used for surgical procedures of the
thorax and the upper abdomen. Its effectiveness has been
showntobeequalorevensuperior to thatofepidural analgesia
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for post-thoracotomy pain.11–14 In experienced hands this
block can be performed safely and effectively. Its failure
rate of 10% is comparable to that reported for epidural anal-
gesia.14 In one investigation the effect of continuos intra- and
postoperative paravertebral block after VATS was evaluated
inninepatients, but thestudydidnot includeacontrolgroup.15
In this double-blind, prospective, randomized trial we
tested the hypothesis that a single-injection thoracic para-
vertebral block reduces pain scores at coughing during the
first 48 h after thoracoscopic surgery in patients receiving
i.v. patient-controlled analgesia (PCA) with morphine.
Methods
The local ethics committee approved the study. The exclu-
sion criteria were: any contraindication to paravertebral
block or to the use of bupivacaine, morphine or paracetamol;
age <18 yr; lack of patient’s cooperation; and the daily use of
opioid for more than 1 week.
The sample size required was calculated choosing a dif-
ference of 25 mm in VAS as the minimum desired difference
between the groups. Setting a=0.05, assuming a standard
deviation of 20 mm (observed in a previous study on thora-
cotomy pain)16 and investigating 17 subjects per group, one
can detect a significant difference of 25 mm with a power of
0.8 (two-sided hypothesis). We decided to analyse 20
patients per group to minimize the chance of insufficient
power, in case the observed variability was higher than
expected. When protocol violations occurred the patient was
excluded and another recruited. All patients gave written
informed consent.
Anaesthetic procedure
Patients were premedicated orally with midazolam 7.5 mg,
20–30 min before anaesthesia. The patients were monitored
using an electrocardiogram, non-invasive arterial blood
pressure device (one measurement every 5 min), pulse oxi-
meter and Bispectral Index (BIS) monitor (Aspect
Medical Systems, Leiden, The Netherlands).
Anaesthesia was conducted using a total i.v. technique
consisting of a target-controlled infusion of propofol using a
Diprifusor Graseby 3500 (Graseby Medical, Watford,
UK), remifentanil infusion, vecuronium and fentanyl.
Endobronchial intubation was performed with a left-sided
double-lumen tube. Target BIS values were set between
30 and 50.
After induction of general anaesthesia, randomization
was performed as follows: in a blind fashion a green or
red cube was drawn from a small bag. When a green
cube was drawn the patient was allocated to the paraverteb-
ral group. When a red cube was drawn the patient was
allocated to the control group. The group allocation was
stratified according to gender.
After positioning patients in the lateral position for the
operation, patients in the paravertebral block group received
a single-injection thoracic paravertebral block.17 The upper
edge of the spinous process of the fifth thoracic vertebral
body was identified by counting down from the seventh
cervical body. With an epidural needle (Tuohy 18 G;
Braun, Melsungen, Germany) the injection point was iden-
tified 3 cm lateral to the midline. The transverse process of
the sixth thoracic vertebra was contacted. The paravertebral
space was punctured by advancing the Tuohy needle over
the superior border of the transverse process. After identi-
fication of the paravertebral space using a loss of resistance
technique, a mixture containing bupivacaine (3.75 mg ml1)
and epinephrine (1:200 000), 0.4 ml kg1, was injected.
In the control group, the skin was penetrated 1 cm with a
Tuohy needle at the same site as in the paravertebral group,
but no drug was injected.
Approximately 30 min before the end of surgery, all
patients received morphine 0.1 mg kg1 i.v. with a morphine
PCA pump (Pharmacia, Deltec SIMS, MN, USA) and
proparacetamol 2 g i.v.
Postoperative management
All patients left the operating room with a morphine PCA
pump. The pump was programmed as follows: bolus dose
1.5 mg, maximum six times per hour in the recovery room
and four times per hour in the ward; lock-out interval 8 min;
no background infusion. All patients received propa-
racetamol 2 g i.v. every 6 h until oral feeding was possible,
and then paracetamol 1 g orally every 6 h for 5 days. Patients
remained in the recovery room for at least 4 h or as long as
indicated. Supplementary oxygen 2–4 litres min1 via nasal
cannulae was administered to all patients for the first 24 h to
maintain oxygen saturation greater than 93%.
Using the visual analogue pain scale (VAS; 0 mm=no
pain, 100 mm=worst pain imaginable), patients were
asked to rate their pain at rest and during coughing every
hour after arrival in the recovery room. Adequate analgesia
was defined as a VAS<30 mm at rest. Inadequate analgesia
was defined as VAS at rest >30 mm despite proper use of
patient-administered morphine. In this case, additional
nurse-administered i.v. boluses of morphine 2 mg were
given. If four boluses did not yield adequate analgesia ket-
orolac 30 mg i.v. every 8 h for a maximum time of 48 h was
added.
Sedation was recorded according to the following
score: 0=alert; 1=drowsy; 2=sleeping, easy to arouse
verbally, does not fall asleep during or immediately after
conversation; 3=sleeping, opens eyes to verbal command,
falls asleep during or immediately after conversation;
4=does not open eyes to verbal command.18 A maximum
score of 3 during the first 12 postoperative hours or 2
during the subsequent observation period was accepted.
In the presence of higher scores the PCA bolus was reduced
by 0.5 mg.
In the presence of nausea, with or without vomiting,
ondansetron 4 mg i.v. was given and repeated once if nausea
persisted (maximum dose 8 mg per day).
Thoracic paravertebral block after thoracoscopic surgery
817
Peak expiratory flow rate (PEFR) was measured using an
AsmaPLAN+ peak flow meter (Vitalograph, Milton Keynes,
UK). In a sitting position after maximal inspiration, the
patient was requested to exhale completely as fast as
possible into the peak flow meter. The mean value of
three measurements was recorded.
Data collection
The age, weight, height and ASA class of each patient was
recorded, as were the type and duration of surgery and the
total dose of propofol and opioid.
The following data were collected after arrival in the
recovery room and 1, 2 and 3 h after surgery: pain intensity
at rest and during coughing by using the VAS score; sedation
score; sensory level as assessed by sensitivity to cold (gel
bag); percutaneous oxygen saturation 3 min after discon-
tinuation of supplementary oxygen (air test); and cumulative
morphine consumption. Length of stay in the recovery room
was also recorded. After 24 and 48 h, patients were asked by
an observer blinded to the group allocation to rate pain at rest
and when coughing using the VAS and to rate their overall
satisfaction with pain management using the following
score: 1=very unhappy, 2=unhappy, 3=happy, 4=very
happy. After 24 and 48 h, PEFR and cumulative morphine
consumption, including nurse-administered boluses, were
recorded.
On discharge from hospital, the following data were
recorded: persistent need for analgesics; total length of
hospital stay after surgery; and the occurrence of any post-
operative complication.
The patients and the observer who collected the postoper-
ative data were blinded to the group allocation.
Statistical analysis
Numerical data of the two groups were compared using the
Student’s t-test or the Mann–Whitney test, depending on
whether the data were distributed normally or not. For
non-Gaussian numerical data collected more than once dur-
ing the study period, the two-way repeated measures ana-
lysis of variance (ANOVA) on ranks was used with time of
measurement as the repeated factor and group as the non-
repeated factor. Categorical data were analysed using
Fisher’s exact test. P<0.05 was considered significant.
The statistical software used was SigmaStat for Windows
version 3.0 (SPSS, Chicago, IL, USA).
Results
Three patients refused consent. A total of 45 patients con-
sented to participate at the preoperative anaesthesia visit.
Five patients were excluded because surgery proceeded
unexpectedly to a thoracotomy (n=3), there were signs of
intravascular injection of bupivacaine with a test dose
observed after two needle positionings (n=1) and loss of
the postoperative data sheet (n=1). Thus, 40 patients were
considered for analysis, 20 in the paravertebral group and
20 in the control group.
The characteristics of the patients, duration of surgery and
total doses of intraoperative opioids and propofol are shown
in Table 1. There was a higher total dose of intraoperative
propofol and fentanyl (P<0.05; Mann–Whitney rank sum
test) used in the paravertebral group.
Surgery started 50 min (median) after injection of the
local anaesthetic (range 30–90). The types of video-assisted
thoracoscopic surgery performed in the two groups are listed
in Table 2. There were always three ports used, scattered
over two or three intercostal spaces.
Table 1 Patient characteristics, duration of surgery and anaesthetic require-
ments in the paravertebral and control groups. Data are mean (range), mean
(SD) or number of patients. n.s., not significant
Paravertebral
group
Control
group
P-value
Sex (F/M) 7/13 8/12 –
Age (yr) 55.4 (19–88) 56.6 (18–84) –
Weight (kg) 70.2 (13.4) 66.7 (12.2 ) –
Height (cm) 171 (10) 171 (11) –
ASA class (I/II/III) 3/9/8 6/7/6 –
Duration of surgery (min) 90 (57) 61 (26) n.s.
Total amount of propofol (mg kg1) 20.6 (8.6) 16.5 (6.8) 0.014
Total amount of fentanyl (mg kg1) 2.3 (1.3) 3.3 (1.2) 0.037
Total amount of remifentanil
(mg kg–1)
17.4 (15.1) 13.3 (8.5) n.s.
Table 2 Distribution of types of video-assisted thoracoscopic surgery in the
paravertebral and control groups (number of patients)
Paravertebral group Control group
Biopsy 7 7
Lung resection 10 6
Pleurodeses 1 5
Resection of intrathoracic tumour 2 2
Control
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Fig 1 Pain course during 48 h after surgery at rest. The median, interquartile
range (box) and the 5th and 95th centiles are shown. The difference between
the groups was statistically significant (P<0.05; two-way repeated measures
ANOVA on ranks).
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The time course of pain scores (VAS) after surgery at rest
and at coughing is shown in Figs 1 and 2 respectively.
The difference in scores between the two groups at coughing
and at rest was statistically significant (P<0.05; two-way
repeated measures ANOVA on ranks). During the stay in
the postoperative anaesthesia care unit, ketorolac was
administered to two and four patients in the paravertebral
and control groups respectively. The number of patients with
VAS scores <30 is shown in Fig. 3. In Fig. 4 the upper and
lower sensory levels of the thoracic dermatomes using cold
are shown for each patient.
Half an hour and 3 h after the operation the median
(25th–75th percentiles) cumulative morphine consumption,
including nurse administered morphine, in the paravertebral
group was 7.3 (6.9–8.0) and 21 mg (9.3–28.3) respectively;
in the control group it was 6.5 (5.5–8.7) and 20 mg (13–37.3)
respectively. The cumulative morphine consumption over
48 h was 69.3 mg (38.8–118.5) in the paravertebral group
and 78.1 mg (38.4–93.5) in the control group (P=0.053; two-
way repeated measures ANOVA on ranks). One and three
patients were treated with ketorolac in the paravertebral
group and the control group respectively. No differ-
ence was found for patient satisfaction with their pain
management.
There was no difference in sedation or the decrease in
oxygen saturation after discontinuation of supplementary
oxygen (air test) between the groups. Twenty-four and
48 h after surgery the groups did not differ with regard to
peak expiratory flow rate (Fig. 5).
The mean length of stay in the postanaesthesia care unit
was 270 (SD 185) and 279 (192) min for the paravertebral
group and the control group respectively (not significant).
The median length of stay in hospital after surgery was 4
and 5 days in the paravertebral and the control groups
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Fig 2 Course of pain on coughing during 48 h after surgery. The median,
interquartile range (box) and the 5th and 95th centiles are shown.
The difference between the groups was statistically significant (P<0.05;
two-way repeated measures ANOVA on ranks).
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paravertebral group
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Fig 4 The spread of the block is illustrated for each patient with upper and
lower levels of sensory block.
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Fig 3 Number of patients with VAS scores <30 mm (i.e. sufficient
analgesia) during 48 h after surgery at rest and on coughing.
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Fig 5 Time course of peak expiratory flow rate (PEFR) preoperatively and
after 24 and 48 h after surgery.
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respectively (P=0.53; Mann–Whitney rank sum test). In one
patient in the control group a respiratory rate below 8 bpm
was documented. The PCA bolus dose was reduced to mor-
phine 1 mg and the respiratory rate normalized. No pulmon-
ary or cardiac complications were observed.
Discussion
We found that single-shot paravertebral block produced
clinically significantly lower pain scores than PCA alone
up to 48 h after surgery (Figs 1–3). Our results confirm
the findings of previous studies showing that single-injection
thoracic paravertebral block reduced the severity of post-
operative pain after breast surgery.19 20
The main effect of paravertebral block in our study was on
VAS scores at rest and on coughing in the first 2 h after the
operation. Interestingly, after 24 and 48 h the scores on
coughing were still lower in the paravertebral block
group. However, at this time a pharmacological effect of
bupivacaine cannot be expected. This finding may be
explained by a pre-emptive effect of the paravertebral
block: reducing the nociceptive input to the central nervous
system in the first hour after surgery may have attenuated
central sensitization, thereby leading to less postoperative
pain.21
The factors affecting the spread of bupivacaine in the
thoracic paravertebral space have been studied by Cheema
and colleagues.22 They found a mean sensory level of 2.2
segments above and 1.4 segments below the level of injec-
tion. In our study, most patients had the upper sensory level
two dermatomes above and below the level of injection. This
spread is sufficient to block pain sensation after thoraco-
scopic surgery. Thus, we think that injections in a multilevel
fashion would unnecessarily expose patients to additional
risks related to punctures.
We found no difference in PEFR between the groups.
However, according to Ballantyne and colleagues23 there
is no correlation between surrogate measures of pulmonary
function and important outcome measures, such as infection
and respiratory failure. Our study was insufficiently powered
for us to comment on such outcomes.
There was no difference in cumulative morphine con-
sumption between the groups. This means that single-shot
paravertebral block alone may not provide adequate
postoperative analgesia and that systemic supplementa-
tion may be necessary. In our setting, single-injection
thoracic paravertebral block was combined with morphine
PCA. However, our results show that in the control
group only 20% of the patients had VAS scores <30 mm
when coughing after 24 and 48 h; this implies inadequate
analgesia.
Thoracic paravertebral block can also be performed using
a catheter technique. Canto and colleagues studied continu-
ous bilateral paravertebral block for conventional cardiac
surgery.24 They found low pain scores during the intensive
care unit stay, with good haemodynamic stability and a low
complication rate. Using a catheter technique would allow
titration of local anaesthetic according to pain scores, which
could improve analgesia and reduce the need for systemic
analgesia.
We conclude that single-shot paravertebral block is an
effective procedure to improve pain treatment after
thoracoscopic surgery. The single dose of bupivacaine
had a prolonged effect on pain scores on coughing for up
to 48 h. Further larger studies are required to evaluate the
effect of paravertebral block after thoracoscopic surgery on
clinically important outcomes, such as complication rates
and the incidence of chronic pain syndrome.
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